Inhibikase Therapeutics所有資訊

Inhibikase Therapeutics | 4：持股變動聲明-高管 Werner Milton H.

04/03 16:51 (美東)

Inhibikase Therapeutics | 4：持股變動聲明-高管 Lees-Rolfe Garth

04/02 17:17 (美東)

Inhibikase Therapeutics | 3：首次持股聲明-高管 Lees-Rolfe Garth

04/02 17:17 (美東)

Inhibikase Therapeutics | 4：持股變動聲明-董事 BERMAN DENNIS N

2023/07/05 21:18 (美東)

Inhibikase Therapeutics | 4：持股變動聲明-董事 Dion Gisele

2023/07/05 21:16 (美東)

Inhibikase Therapeutics | 4：持股變動聲明-董事 GRINT PAUL C

2023/07/05 21:12 (美東)

Inhibikase Therapeutics | 4：持股變動聲明-董事 Freeman Roy Lester

2023/07/05 21:11 (美東)

Inhibikase Therapeutics | 4：持股變動聲明-高管 Werner Milton H.

2023/03/03 17:00 (美東)

Inhibikase Therapeutics | 4：持股變動聲明-高管 FRATTAROLI JOSEPH

2023/03/03 17:00 (美東)

Inhibikase Therapeutics | SC 13D：超過5%持股股東披露文件-FiveT Investment Management Ltd(4.78%),FiveT Capital AG(4.78%)

2023/02/24 12:27 (美東)

Inhibikase Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Milton H. Werner(19.68%)

2023/02/15 19:45 (美東)

Inhibikase Therapeutics | D：發行公告

2023/02/07 16:48 (美東)

Inhibikase Therapeutics | SC 13D：超過5%持股股東披露文件-FiveT Investment Management Ltd(4.12%),FiveT Capital AG(4.12%)

2023/01/31 11:59 (美東)

Inhibikase Therapeutics | 4：持股變動聲明

2022/09/06 17:08 (美東)

Inhibikase Therapeutics | 3：首次持股聲明-董事 Dion Gisele

2022/09/06 17:06 (美東)

Inhibikase Therapeutics | 4：持股變動聲明

2022/08/16 16:25 (美東)

Inhibikase Therapeutics | 4：持股變動聲明

2022/06/28 21:00 (美東)

Inhibikase Therapeutics | 4：持股變動聲明

2022/06/28 21:00 (美東)

Inhibikase Therapeutics | 4：持股變動聲明

2022/06/28 21:00 (美東)

Inhibikase Therapeutics | 4：持股變動聲明

2022/06/28 21:00 (美東)